ELEVANCE HEALTH INC (ELV) Stock Price, Forecast & Analysis
USA • New York Stock Exchange • NYSE:ELV • US0367521038
ELV Key Statistics, Chart & Performance
The current stock price of ELV is 330.25 USD. In the past month the price decreased by -10.91%. In the past year, price decreased by -15.16%.
ELV Technical Analysis
ELV Fundamental Analysis
ChartMill assigns a fundamental rating of 4 / 10 to ELV. ELV has a medium profitability rating, but doesn't score so well on its financial health evaluation.
ELV Financial Highlights
Over the last trailing twelve months ELV reported a non-GAAP Earnings per Share(EPS) of 30.17. The EPS decreased by -8.49% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 2.84% | ||
| ROA | 4.66% | ||
| ROE | 12.9% | ||
| Debt/Equity | 0.71 |
ELV Forecast & Estimates
28 analysts have analysed ELV and the average price target is 401.08 USD. This implies a price increase of 21.45% is expected in the next year compared to the current price of 330.25.
For the next year, analysts expect an EPS growth of -13.28% and a revenue growth -2.33% for ELV
ELV Ownership
ELV Latest News, Press Relases and Analysis
ELV Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| UNH | UNITEDHEALTH GROUP INC | 15.49 | 247.494B | ||
| HUM | HUMANA INC | 14.56 | 21.805B | ||
| CNC | CENTENE CORP | 13.63 | 19.479B | ||
| HQY | HEALTHEQUITY INC | 16.66 | 6.694B | ||
| MOH | MOLINA HEALTHCARE INC | 8.82 | 6.397B | ||
| ALHC | ALIGNMENT HEALTHCARE INC | 210.42 | 4.128B | ||
| PGNY | PROGYNY INC | 22.62 | 1.855B | ||
| CLOV | CLOVER HEALTH INVESTMENTS CO | N/A | 1.095B |
Related stock screener links
View all stocks in the Managed Health Care Industry | View all stocks in the Health Care Sector | View all stocks on the New York Stock Exchange Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About ELV
Company Profile
Elevance Health, Inc. operates as a health company, which engages in improving lives and communities, and making healthcare simpler. The company is headquartered in Indianapolis, Indiana. The company went IPO on 2001-10-30. The company operates as a health insurer in the United States. The firm operates through four segments: Health Benefits, CarelonRx, Carelon Services and Corporate & Other. The Health Benefits segment offers a comprehensive suite of health plans and services to its Individual, Employer Group risk-based, Employer Group fee-based, BlueCard, Medicare, Medicaid and Federal Employee Program (FEP) members. The Health Benefits segment also offers health products on a full-risk basis. The CarelonRx segment includes its pharmacy services business. CarelonRx markets and offers pharmacy services to its affiliated health plan customers, as well as to external customers outside of the health plans. The Carelon Services segment integrates physical, behavioral, pharmacy, and social services by offering an array of healthcare-related services and capabilities to internal and external customers through its Carelon Health and Carelon Insights businesses.
Company Info
ELEVANCE HEALTH INC
220 Virginia Avenue
Indianapolis INDIANA US
Employees: 103158
Phone: 18003311476
ELEVANCE HEALTH INC / ELV FAQ
Can you describe the business of ELEVANCE HEALTH INC?
Elevance Health, Inc. operates as a health company, which engages in improving lives and communities, and making healthcare simpler. The company is headquartered in Indianapolis, Indiana. The company went IPO on 2001-10-30. The company operates as a health insurer in the United States. The firm operates through four segments: Health Benefits, CarelonRx, Carelon Services and Corporate & Other. The Health Benefits segment offers a comprehensive suite of health plans and services to its Individual, Employer Group risk-based, Employer Group fee-based, BlueCard, Medicare, Medicaid and Federal Employee Program (FEP) members. The Health Benefits segment also offers health products on a full-risk basis. The CarelonRx segment includes its pharmacy services business. CarelonRx markets and offers pharmacy services to its affiliated health plan customers, as well as to external customers outside of the health plans. The Carelon Services segment integrates physical, behavioral, pharmacy, and social services by offering an array of healthcare-related services and capabilities to internal and external customers through its Carelon Health and Carelon Insights businesses.
Can you provide the latest stock price for ELEVANCE HEALTH INC?
The current stock price of ELV is 330.25 USD. The price increased by 1.42% in the last trading session.
Does ELV stock pay dividends?
ELEVANCE HEALTH INC (ELV) has a dividend yield of 2.07%. The yearly dividend amount is currently 6.8.
What is the ChartMill rating of ELEVANCE HEALTH INC stock?
ELV has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 4 out of 10.
How is the market expecting ELV stock to perform?
28 analysts have analysed ELV and the average price target is 401.08 USD. This implies a price increase of 21.45% is expected in the next year compared to the current price of 330.25.
How is the valuation of ELEVANCE HEALTH INC (ELV) based on its PE ratio?
The PE ratio for ELEVANCE HEALTH INC (ELV) is 10.95. This is based on the reported non-GAAP earnings per share of 30.17 and the current share price of 330.25 USD.
Can you provide the upcoming dividend date for ELEVANCE HEALTH INC?
The next ex-dividend date for ELEVANCE HEALTH INC (ELV) is March 10, 2026.